Multiple sclerosis (MS) is a demyelinating disease of the CNS. Epstein-Barr virus (EBV)
contributes to the MS pathogenesis because high levels of EBV EBNA 386–405-specific …

Abstract Immune responses to Epstein–Barr virus (EBV) infection synergize with the main
genetic risk factor HLA‐DRB1* 15: 01 (HLA‐DR15) to increase the likelihood to develop the …

Symptomatic primary Epstein-Barr virus (EBV) infection and elevated humoral immune
responses to EBV are associated with an increased risk of developing multiple sclerosis …

Epstein-Barr virus (EBV) infection, history of infectious mononucleosis (IM) and HLA-A and
DRB1 have all been proposed as risk factors for multiple sclerosis (MS). Our aim was to …

Accumulating evidence implicates Epstein-Barr virus (EBV) as an etiological factor in
multiple sclerosis (MS). If EBV is a “driver” that causes antiviral immunity with associated …

Mounting evidence indicates that infection with Epstein–Barr virus (EBV) has a major role in
the pathogenesis of multiple sclerosis (MS). Defective elimination of EBV‐infected B cells by …

Multiple sclerosis (MS) is a T cell driven autoimmune disease of the central nervous system
(CNS). Despite its association with Epstein-Barr Virus (EBV), how viral infections promote …

Compelling evidence indicates that Epstein Barr virus (EBV) infection is a prerequisite for
multiple sclerosis (MS). The disease may arise from a complex interplay between latent EBV …

Multiple sclerosis (MS) is an inflammatory neurological disease that is widely regarded as
the outcome of complex interactions between a genetic predisposition and an environmental …

Epstein–Barr virus (EBV) is a ubiquitous human lymphotropic herpesvirus with a well-
established causal role in several cancers. Recent studies have provided compelling …